ProMIS Neurosciences, Inc. (PMN)
ProMIS Neurosciences. ProMIS™ Neurosciences, Inc., is a development stage biotech company that discovers and develops precision therapeutics and...
Read Promisneurosciences.com news digest here: view the latest ProMIS Neurosciences articles and content updates right away or get to their most visited pages. Promisneurosciences.com is not yet rated by Alexa and its traffic estimate is unavailable. It seems that ProMIS Neurosciences content is notably popular in Canada. We haven’t detected security issues or inappropriate content on Promisneurosciences.com and thus you can safely use it. Promisneurosciences.com is hosted with Amazon Technologies Inc. (United States) and its basic language is English.
Content verdict: Safe
Website availability: Live
Language: English
Last check:
-
N/A
Visitors daily -
N/A
Pageviews daily -
N/A
Google PR -
N/A
Alexa rank
Best pages on Promisneurosciences.com
-
ProMIS Neurosciences, Inc. (PMN)
A Revolutionary Breakthrough in Precision Medicine Based on the leading science of Dr. Neil Cashman, our proprietary target discovery engine utilizes two computational discovery technologies, ProMIS™ ...
-
New Light Shed on the Origin of Neurotoxic Amyloid-β Prions - ProMIS Neurosciences
ProMIS™ Neurosciences, Inc., is a development stage biotech company that discovers and develops precision therapeutics and companion diagnostics for early detection and effective treatment of neurodeg...
-
Team Management Team and Board of Directors ProMIS™ Neurosciences, Inc., is a development stage biotech company that discovers and develops game changing precision therapeutics for treatment of neurod...
Promisneurosciences.com news digest
-
2 years
ProMIS Neurosciences Appoints Renowned Neuroscientists, Dr. Guy Rouleau and Dr. ...
TORONTO, Ontario and CAMBRIDGE, Mass. , Feb. 03, 2022 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a biotechnology company focused on the discovery and development of antibody therapeutics targeting misfolded proteins such...
-
2 years
ProMIS Neurosciences Appoints Internationally Recognized Neuroscientist Dr. Cher...
TORONTO, Ontario and CAMBRIDGE, Mass., Jan. 27, 2022 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a biotechnology company focused on the discovery and development of antibody therapeutics targeting misfolded proteins such...
-
2 years
ProMIS Neurosciences Announces Antibody Program for Schizophrenia Therapy and Re...
TORONTO, Ontario and CAMBRIDGE, Mass., Jan. 18, 2022 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a biotechnology company focused on the discovery and development of antibody therapeutics targeting misfolded proteins such...
-
2 years
ProMIS Neurosciences to Participate in the Biotech Showcase 2022 Virtual Panel D...
TORONTO, Ontario and CAMBRIDGE, Mass., Jan. 07, 2022 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a biotechnology company focused on the discovery and development of antibody therapeutics targeting misfolded proteins such...
Domain history
| Web host: | Amazon Technologies Inc. |
| Registrar: | GoDaddy.com, LLC |
| Registrant: | Registration Private (Domains By Proxy, LLC) |
| Updated: | July 09, 2023 |
| Expires: | July 08, 2024 |
| Created: | July 08, 2015 |
Whois record
Safety scores
Trustworthiness
N/AChild safety
N/A
